Laddar...

Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis

BACKGROUND: In 2016, the global number of individuals living with dementia was 43.8 million, representing a 117% increase from 1990—mainly due to increases in aging and population growth. Up to 90% of individuals with dementia experience neuropsychiatric symptoms (NPS). However, the limitations of c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Can J Psychiatry
Huvudupphovsmän: Bahji, Anees, Meyyappan, Arthi Chinna, Hawken, Emily R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2019
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7265608/
https://ncbi.nlm.nih.gov/pubmed/31835954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0706743719892717
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!